Our ChIP-seq data detected robust Ikaros binding peaks on the promoter regions of both BCL6 and BACH2 in B-ALL cell lines and primary B-ALL cells from patients. Here, BCL6 is linked to precursor B-cell acute lymphoblastic leukemia.